| scholarly article | Q13442814 |
| P2093 | author name string | Leah R Hanson | |
| William H Frey | |||
| Marna E Ericson | |||
| Aleta L Svitak | |||
| Dan B Renner | |||
| Nathan J Gallus | |||
| P2860 | cites work | Mechanisms of nuclear translocation of insulin | Q33875142 |
| Endocytic and exocytic pathways of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo | Q34381914 | ||
| Ultrastructural evidence for the accumulation of insulin in nuclei of intact 3T3-L1 adipocytes by an insulin-receptor mediated process | Q34589069 | ||
| Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial | Q35679839 | ||
| The source of cerebral insulin | Q35749604 | ||
| Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects | Q37295536 | ||
| Intranasal delivery to the central nervous system: mechanisms and experimental considerations | Q37624592 | ||
| Effect of intranasal insulin on cognitive function: a systematic review | Q37967672 | ||
| Insulin receptors are widely distributed in the central nervous system of the rat | Q40141863 | ||
| Astrocytes Modulate Distribution and Neuronal Signaling of Leptin in the Hypothalamus of Obese A vy Mice | Q41829135 | ||
| Ensheathment of the olfactory nerves in the adult rat. | Q42455569 | ||
| Olfactory ensheathing cells and olfactory nerve fibroblasts maintain continuous open channels for regrowth of olfactory nerve fibres | Q42480229 | ||
| Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat. | Q42525697 | ||
| Visualization of in vivo olfactory uptake and transfer using fluorescein dextran | Q44223179 | ||
| Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents | Q46398113 | ||
| Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy | Q48823757 | ||
| Uptake of exogenous proteins in mouse olfactory cells | Q48864161 | ||
| P433 | issue | 12 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 1709-1714 | |
| P577 | publication date | 2012-07-04 | |
| P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
| P1476 | title | Intranasal delivery of insulin via the olfactory nerve pathway | |
| P478 | volume | 64 |
| Q34079647 | Agile delivery of protein therapeutics to CNS |
| Q47932196 | Alfalfa-derived HSP70 administered intranasally improves insulin sensitivity in mice |
| Q98171198 | Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches |
| Q64115973 | Distribution of insulin in trigeminal nerve and brain after intranasal administration |
| Q33844966 | Enhancing effect of borneol and muscone on geniposide transport across the human nasal epithelial cell monolayer |
| Q36685572 | Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders |
| Q38605675 | Impaired insulin action in the human brain: causes and metabolic consequences |
| Q28079442 | Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood |
| Q90030377 | Insulin resistance is associated with impaired olfactory function in adult patients with type 1 diabetes: A cross-sectional study |
| Q37615358 | Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model |
| Q90236410 | Intranasal administration of dantrolene increased brain concentration and duration |
| Q57292417 | Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia |
| Q41979813 | Intranasal delivery of a peptide with antidepressant-like effect |
| Q38553213 | Intranasal delivery: circumventing the iron curtain to treat neurological disorders |
| Q38569775 | Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier |
| Q24601034 | Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence |
| Q38646201 | Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring |
| Q31153213 | Intranasal insulin treatment of an experimental model of moderate traumatic brain injury. |
| Q48105305 | Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure. |
| Q37142166 | Intranasal treatment of central nervous system dysfunction in humans |
| Q37254559 | Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial |
| Q47906548 | Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse. |
| Q57039827 | Post-injury Nose-to-Brain Delivery of Activin A and SerpinB2 Reduces Brain Damage in a Mouse Stroke Model |
| Q55406585 | RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome. |
| Q43669948 | Targeting the brain through the nose. Effects of intranasally administered insulin |
| Q43523795 | The design and delivery of a PKA inhibitory polypeptide to treat SCA1. |
| Q47157230 | mPEG-PLA/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus |
Search more.